Connect with us

Brazil health regulator cancels clinical study for Bharat Biotech vaccine

HBS Reporting

Brazil health regulator cancels clinical study for Bharat Biotech vaccine

Brazil health regulator cancels clinical study for Bharat Biotech vaccine

BRASILIA, July 26 (Reuters) – Brazilian health regulator Anvisa on Monday said it had canceled a clinical study for the Covaxin vaccine for COVID-19 developed by India’s Bharat Biotech, amid allegations of irregularities in the government’s efforts to buy millions of doses of the shot.

Bharat on Friday said it had terminated a memorandum of understanding with the local partner company acting as its intermediary in Brazil, with Anvisa saying on Monday that the trials could not go forward as a result and would be canceled.

Anvisa had previously suspended the trials temporarily.

Continue Reading
You may also like...
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More in HBS Reporting